Business Context and Reporting Period
This Form 8-K Current Report was filed by Moderna, Inc. on June 4, 2020. The filing discloses a significant change in executive leadership, specifically the appointment of a new Chief Financial Officer (CFO) and the departure of the incumbent CFO.
Key Financial Metrics
The filing does not provide operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The financial data contained within this document is limited to the compensation package for the newly appointed executive.
- Base Salary: $600,000 annually.
- Annual Cash Bonus Target: 50% of base salary ($300,000).
- Initial Equity Grant Value: $8,600,000 (valued as of the July 6, 2020 grant date).
- Annual Equity Award Target: $4,000,000 (subject to approval and pro-rating).
Material Changes
The primary material change reported is the transition of the Chief Financial Officer role:
- Appointment: David W. Meline was appointed as Chief Financial Officer, effective June 8, 2020.
- Departure: Lorence Kim stepped down as Chief Financial Officer effective June 8, 2020, transitioning to an advisor role through August 2020.
- Executive Background: Mr. Meline brings prior experience as CFO of Amgen Inc. (2014–2019), 3M Company (2011–2014), and General Motors Company (over 20 years).
Guidance, Outlook, and Risks
This filing does not contain updated financial guidance, operational outlook, or new risk factors. The document focuses exclusively on the terms of employment for the new CFO. The equity grants are subject to vesting schedules over four years and specific service conditions, including a provision for continued vesting through strategic consulting arrangements if the executive remains with the company for at least two years.
Investor Verification Checklist
- Verify the exact vesting schedule and performance conditions for the $8.6 million initial equity grant and the $4 million annual equity award.
- Confirm the transition timeline for Lorence Kim's advisory role and any potential consulting fees associated with it.
- Review the press release (Exhibit 99.1) for any additional strategic context regarding the leadership change.
- Check subsequent filings for the actual grant date valuation and share count issued on July 6, 2020.
